Smartlab Europe

PerkinElmer unveils ChemBioOffice Version 13.0

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Smart Inspection Systems with HV Leak Detection Technology

The convergence of digital transformation and precision engineering has given rise to a new generation of quality control in pharmaceutical manufacturing. Smart inspection systems with HV leak detection technology utilize advanced sensors and real-time data analytics to identify microscopic structural flaws in sterile packaging with unprecedented accuracy. By automating the detection of leaks that are invisible to the human eye, these intelligent systems significantly enhance the reliability of the manufacturing process, ensuring that every container meets the highest standards of safety and sterility.

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...
- Advertisement -

PerkinElmer has launched the latest version of ChemBioOffice Informatics Suite to accelerate the discovery process through increased productivity and data sharing.

Version 13.0 adds improvements to the ChemBioDraw and ChemBio3D modules while providing secure cloud storage for improved data sharing.

The ChemBioOffice suite helps chemists and biologists to track their work and provides individual scientists within an organization the tools they need to create publication-ready drawings of compounds, reactions, materials and their properties for use in electronic laboratory notebooks and databases as well as for querying chemical databases.

PerkinElmer Informatics general manager Michael Stapleton said, “We are very excited to provide chemists and biologists with the new ChemBioOffice Suite, a premium tool developed to help scientists turn data into actionable information and make decisions with greater confidence, thereby accelerating their discovery process.”

The improved biopolymer toolbar of the ChemBioDraw program allows fast modifications to larger therapeutic agents and molecular structures such as amino acids, peptides, RNA, DNA and nucleotides.

With the ChemBio3D program, synthetic chemists and biologists will be able to generate 3D models and assess the shape and properties of small molecules and biochemical compounds.

The ChemBio3D program, which provides access to other computational and molecular modeling programs, can evaluate data input and provide important information such as the degree of fit of compounds into a receptor.

Latest stories

Related stories

Smart Inspection Systems with HV Leak Detection Technology

The convergence of digital transformation and precision engineering has given rise to a new generation of quality control in pharmaceutical manufacturing. Smart inspection systems with HV leak detection technology utilize advanced sensors and real-time data analytics to identify microscopic structural flaws in sterile packaging with unprecedented accuracy. By automating the detection of leaks that are invisible to the human eye, these intelligent systems significantly enhance the reliability of the manufacturing process, ensuring that every container meets the highest standards of safety and sterility.

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

It’s Time for the 3rd Generation of Patient Recruitment

Key Takeaways 80% of clinical trials experience enrolment delays and massive...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »